Oxidative Modification, Inflammation and Amyloid in the Normal and Diabetic Cat Pancreas

Acharya, 2010, Islets and their antioxidant defense, Islets, 2, 225, 10.4161/isl.2.4.12219 Bast, 2002, Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells, Diabetologia, 45, 867, 10.1007/s00125-002-0846-1 Boni-Schnetzler, 2008, Insulitis in type 2 diabetes, Diabetes, Obesity and Metabolism, 10, 201, 10.1111/j.1463-1326.2008.00950.x Boyle, 2010, Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence, Population Health Metrics, 8, 29, 10.1186/1478-7954-8-29 Brender, 2010, Role of zinc in human islet amyloid polypeptide aggregation, Journal of the American Chemical Society, 132, 8973, 10.1021/ja1007867 Donath, 2005, Mechanisms of beta-cell death in type 2 diabetes, Diabetes, 54, S108, 10.2337/diabetes.54.suppl_2.S108 Gasa, 2001, High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets, Pancreas, 22, 307, 10.1097/00006676-200104000-00013 Höppener, 2002, Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?, Molecular and Cellular Endocrinology, 197, 205, 10.1016/S0303-7207(02)00266-6 Hui, 2001, Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells, Diabetes, 50, 785, 10.2337/diabetes.50.4.785 Ihara, 1999, Hyperglycemia causes oxidative stress in pancreatic beta-cells of gk rats, a model of type 2 diabetes, Diabetes, 48, 927, 10.2337/diabetes.48.4.927 Jaikaran, 2001, Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology, Biochimica et Biophysica Acta, 1537, 179, 10.1016/S0925-4439(01)00078-3 Johnson, 1989, Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells, American Journal of Pathology, 135, 245 Larsen, 2009, Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes, Diabetes Care, 32, 1663, 10.2337/dc09-0533 Li, 2009, Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction, Journal of Biological Chemistry, 284, 23602, 10.1074/jbc.M109.024323 Lutz, 1996, Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats, Canadian Veterinary Journal, 37, 27 Lutz, 1994, Frequency of pancreatic amyloid deposition in cats from south-eastern Queensland, Australian Veterinary Journal, 71, 254, 10.1111/j.1751-0813.1994.tb03422.x Lutz, 1997, Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques, Journal of Comparative Pathology, 116, 157, 10.1016/S0021-9975(97)80073-4 Ma, 1998, Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats, Amyloid, 5, 255, 10.3109/13506129809007298 Meier, 2006, Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP, American Journal of Physiology, Endocrinology and Metabolism, 291, E1317, 10.1152/ajpendo.00082.2006 Modak, 2011, Control of hyperglycemia significantly improves oxidative stress profile of pancreatic islets, Islets, 3, 234, 10.4161/isl.3.5.15941 Mulder, 1995, Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents, Molecular and Cellular Endocrinology, 114, 101, 10.1016/0303-7207(95)03646-O Mulder, 1996, Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats, Diabetologia, 39, 649, 10.1007/BF00418536 O'Brien, 2002, Pathogenesis of feline diabetes mellitus, Molecular and Cellular Endocrinology, 197, 213, 10.1016/S0303-7207(02)00265-4 O'Brien, 1993, Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus, Veterinary Pathology, 30, 317, 10.1177/030098589303000401 O'Brien, 1986, Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats, Journal of Comparative Pathology, 96, 357, 10.1016/0021-9975(86)90031-9 Pieber, 1993, Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia, American Journal of Physiology, 265, E446 Prahl, 2007, Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals, Journal of Feline Medicine and Surgery, 9, 351, 10.1016/j.jfms.2007.02.004 Rieder, 2008, Canine and feline diabetes mellitus: a retrospective epidemiological study (1996–2006), Tierarztliche Praxis; Ausgabe K, Kleintiere/Heimtiere, 36, 169, 10.1055/s-0038-1622674 Robertson, 2004, Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes, Diabetes, 53, S119, 10.2337/diabetes.53.2007.S119 Weise, 2010, Interaction of HIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of HIAPP oligomers, Chembiochem, 11, 1280, 10.1002/cbic.201000039 Westermark, 2011, Islet amyloid polypeptide, islet amyloid, and diabetes mellitus, Physiology Reviews, 91, 795, 10.1152/physrev.00042.2009 Westermark, 1990, Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation, Proceedings of the National Academy of Sciences USA, 87, 5036, 10.1073/pnas.87.13.5036 Xu, 2008, Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas, Cell, 132, 197, 10.1016/j.cell.2007.12.015 Zhao, 2009, Amyloid oligomers in diabetic and nondiabetic human pancreas, Translational Research, 153, 24, 10.1016/j.trsl.2008.10.009